Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • Index
    • Overview and Device Description
    • Information provided by the Manufacturer
    • Design and Manufacturing Information
    • GSPR
    • Benefit-Risk Analysis and Risk Management
      • R-TF-013-001 Risk management plan
      • R-TF-013-002 Risk management record
      • R-TF-013-003 Risk management report
      • R-TF-013-004 EN 14971 Checklist
    • Product Verification and Validation
    • Post-Market Surveillance
  • Legit.Health Plus Version 1.1.0.1
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Grants
  • Pricing
  • Public tenders
  • Legit.Health Plus Version 1.1.0.0
  • Benefit-Risk Analysis and Risk Management
  • R-TF-013-004 EN 14971 Checklist

R-TF-013-004 EN 14971 Checklist

EN ISO 14971:2019 Checklist​

This document provides a comprehensive checklist to demonstrate compliance with the requirements of the harmonized standard EN ISO 14971:2019 Medical devices - Application of risk management to medical devices.

4. General requirements for risk management​

ReferenceRequirementRequiredFulfilled in
4.1Risk management processTRUESection Risk management process in document GP-013 Risk management
4.2Management responsibilitiesTRUESection Responsibilities and authorities in document R-TF-013-001 Risk management plan
4.3Qualifications of personnelTRUEDocument Quality Manual, section Human resources and procedure GP-002 Personnel training and skills
4.4Risk management planTRUEDocument R-TF-013-001 Risk management plan
4.5Risk management fileTRUEAll risk management documents are archived in the DHF and technical documentation

5. Risk analysis​

ReferenceRequirementRequiredFulfilled in
5.1Risk analysis process--
5.2Intended use and identification of characteristics related to the safety of the medical deviceTRUESection Scope in document R-TF-013-001 Risk management plan and section Intended use and identification of the qualitative and quantitative characteristics in R-TF-013-003 Risk management report
5.3Identification of hazardsTRUESection Hazard identification in document R-TF-013-001 Risk management plan and document R-TF-013-002 Risk management record
5.4Estimation of the risk(s) for each hazardous situationTRUESection Risk estimation in document R-TF-013-001 Risk management plan and document R-TF-013-002 Risk management record

6. Risk evaluation​

ReferenceRequirementRequiredFulfilled in
6.1Risk evaluationTRUESection Risk evaluation in document R-TF-013-001 Risk management plan and section Evaluation in document R-TF-013-002 Risk management record

7. Risk control​

ReferenceRequirementRequiredFulfilled in
7.1Risk control option analysis--
7.1Risk control option analysisTRUESection Risk control in document R-TF-013-001 Risk management plan and sections Risk control measures and Mitigation in document R-TF-013-002 Risk management record
7.2Implementation of risk control measures--
7.2Implementation of risk control measuresTRUESection Risk control measures and Mitigation in document R-TF-013-002 Risk management record
7.3Residual risk evaluation--
7.3Residual risk evaluationTRUESection Residual risk evaluation in document R-TF-013-001 Risk management plan and section Residual risk in document R-TF-013-002 Risk management record
7.4Benefit-risk analysis--
7.4Benefit-risk analysisTRUESection Benefit-risk analysis in document R-TF-013-001 Risk management plan and section Benefit-risk ratio acceptability in document R-TF-013-003 Risk management report
7.5Risks arising from risk control measures--
7.5Risks arising from risk control measuresTRUESection Risks arising from risk control measures in document R-TF-013-001 Risk management plan and document R-TF-013-002 Risk management record where new risks introduced by control measures are identified and controlled
7.6Completeness of risk control--
7.6Completeness of risk controlTRUESection Completeness of risk control in document R-TF-013-001 Risk management plan and section Risk management review in document R-TF-013-003 Risk management report

8. Evaluation of overall residual risk acceptability​

ReferenceRequirementRequiredFulfilled in
8Evaluation of overall residual risk acceptabilityTRUESection Overall residual risk evaluation in document R-TF-013-001 Risk management plan and section Overall residual risk in document R-TF-013-003 Risk management report

9. Risk management review​

ReferenceRequirementRequiredFulfilled in
9Risk management reviewTRUESection Risk management review in document R-TF-013-001 Risk management plan and section Risk management review in document R-TF-013-003 Risk management report

10. Production and post-production activities​

ReferenceRequirementRequiredFulfilled in
10.1Information collection and review--
10.1Information collection and reviewTRUESection Production and post-production information in document R-TF-013-001 Risk management plan, procedure GP-007 Post-market surveillance, and document R-TF-007-001 Post-market surveillance (PMS) plan
10.2Review of information--
10.2Review of informationTRUESection Production and post-production information in document R-TF-013-001 Risk management plan, procedure GP-007 Post-market surveillance, and documents R-TF-007-002 Post-market surveillance (PMS) report
10.3Actions resulting from information review--
10.3Actions resulting from information reviewTRUEProcedure GP-023 Change control management, procedure GP-006 Non-conformity, Corrective and Preventive actions, and procedure GP-004 Vigilance system

Risk management documentation summary​

The risk management process for Legit.Health Plus is comprehensively documented across the following key documents:

DocumentDescription
GP-013 Risk managementGeneral procedure defining the risk management process, responsibilities, and methodologies applied throughout the product lifecycle
R-TF-013-001 Risk management planSpecific risk management plan for Legit.Health Plus, defining activities, criteria for risk acceptability, and information to be collected
R-TF-013-002 Risk management recordDetailed record of all identified hazards, hazardous situations, risk estimation, control measures, verification activities, and residual risk evaluation
R-TF-013-003 Risk management reportRisk management report including intended use analysis, benefit-risk analysis, overall residual risk evaluation, and risk management review
R-TF-007-001 Post-market surveillance planPost-market surveillance plan describing activities for collecting and reviewing production and post-production information
R-TF-007-002 Post-market surveillance reportPost-market surveillance reports documenting review of production and post-production information and impact on risk management activities
GP-023 Change control managementProcedure for managing changes that may impact device safety and performance, including risk assessment
GP-006 Non-conformity, CAPAProcedure for handling non-conformities, implementing corrective and preventive actions, including risk re-evaluation
GP-004 Vigilance systemProcedure for identifying, documenting, and reporting incidents and near-incidents, and evaluating their impact on risk management

Compliance statement​

This checklist demonstrates that Legit.Health Plus complies with all applicable requirements of EN ISO 14971:2019 for the application of risk management to medical devices. All requirements have been fulfilled through the comprehensive risk management system documented in the procedures and records listed above.

The risk management process is integrated throughout the entire device lifecycle, from initial concept and design through production, post-market surveillance, and decommissioning. The process is continuously reviewed and updated based on new information from production and post-production activities.

Record signature meaning​

  • Author: JD-004
  • Reviewer: JD-003
  • Approval: JD-005
Previous
R-TF-013-003 Risk management report
Next
Product Verification and Validation
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)